Cargando…
Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
Background: Duchenne muscular dystrophy (DMD) is a fatal muscle wasting disease caused by mutations in the dystrophin gene. Due to their phenotypic similarity to human patients, large animal models are invaluable tools for pre-clinical trials. The DE50-MD dog is a relatively new model of DMD, and ca...
Autores principales: | Riddell, Dominique O., Hildyard, John C. W., Harron, Rachel C. M., Wells, Dominic J., Piercy, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111359/ https://www.ncbi.nlm.nih.gov/pubmed/35600245 http://dx.doi.org/10.12688/wellcomeopenres.17398.2 |
Ejemplares similares
-
Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
por: Riddell, Dominique O., et al.
Publicado: (2022) -
The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy
por: Hildyard, John C.W., et al.
Publicado: (2022) -
Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy
por: Hornby, Natasha L., et al.
Publicado: (2021) -
Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy
por: Crawford, Abbe H., et al.
Publicado: (2022) -
Investigating Synthetic Oligonucleotide Targeting of Mir31 in Duchenne Muscular Dystrophy
por: Hildyard, John CW, et al.
Publicado: (2016)